(105 days)
Not Found
No
The description focuses on servo-controlled thermal feedback and alarm systems, which are traditional control mechanisms, and there is no mention of AI or ML terms or concepts.
Yes.
The device provides infrared heat to infants who are unable to maintain thermoregulation, which is a therapeutic intervention to facilitate their transition or provide a controlled microenvironment for their development.
No
The device description indicates that the Lullaby™ Warmer is used to provide heat and maintain a pre-set temperature for infants, facilitating thermoregulation. Its primary function is therapeutic/supportive, not diagnostic. It does not identify, detect, or monitor a disease, condition, or health status for diagnostic purposes, although it does provide monitoring based on alarms and temperature feedback.
No
The device description clearly indicates it is a physical radiant warmer with hardware components (heating element, sensors, alarm systems, servo control mechanism) designed to provide a controlled microenvironment and monitor the infant. It is not solely software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Lullaby™ Warmer is a medical device that provides external heat to infants. It does not perform any tests on biological samples.
- Intended Use: The intended use is to provide thermoregulation for infants, not to diagnose or monitor a condition through analysis of biological samples.
- Device Description: The description focuses on providing a controlled microenvironment and monitoring the baby's temperature, not on analyzing biological samples.
Therefore, the Lullaby™ Warmer falls under the category of a therapeutic or supportive medical device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
Infant radiant warmers provide infrared heat in a controlled manner to infants who are unable to maintain thermoregulation based on their own physiology. Infant radiant Warmers may be used to facilitate the newborn's transition to the external environment or to rrovide a controlled open microenvironment.
Product codes (comma separated list FDA assigned to the subject device)
FMT
Device Description
The Lullaby™ Warmer is a radiant warmer which provides a micr-oenvironment for a premature, new born baby which otherwise might have very little chance of survival as it will not be able to maintain, by itself, its core body temperature. The Lullaby™ Warmer provides a means for the care giver to monitor the baby continuously by giving timely feedback via the different alarm systems and servo controlled thermal feedback mechanism while maintaining a pre-set temperature and thus ensures that the neonate slowly develops the internal organs to enable it to maintain its body temperature.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
infants, newborn
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Summary of Non-Clinical Tests:
Verification and Testing activities establish the performance, functionality, usability, safety, and reliability characteristics of Lullaby™ Warmer. The Lullaby™ Warmer comply with voluntary standards as detailed in Section 09, 15, 16, 17 and 18 of this premarket submission. The following quality assurance measures were applied to the development of the system:
Risk Analysis
Requirements Reviews
Design Reviews
Summary of Simulated Use Setting:
The Design verification of Lullaby™ Warmer has been divided into several protocols that include electrical, mechanical, safety Testing, reliability, and system design verification protocols. The performance testing included testing on unit level, system level, as well as usability and safety parameters. The results of the Design verification testing protocols have been documented in Section 18 of this 510(k) application. The results demonstrate that the Lullaby™ Warmer meets all design requirements and performance claims. The subject of this premarket submission, Lullaby™ Warmer, did not require clinical studies to support substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5130 Infant radiant warmer.
(a)
Identification. The infant radiant warmer is a device consisting of an infrared heating element intended to be placed over an infant to maintain the infant's body temperature by means of radiant heat. The device may also contain a temperature monitoring sensor, a heat output control mechanism, and an alarm system (infant temperature, manual mode if present, and failure alarms) to alert operators of a temperature condition over or under the set temperature, manual mode time limits, and device component failure, respectively. The device may be placed over a pediatric hospital bed or it may be built into the bed as a complete unit.(b)
Classification. Class II (Special Controls):(1) The Association for the Advancement of Medical Instrumentation (AAMI) Voluntary Standard for the Infant Radiant Warmer;
(2) A prescription statement in accordance with § 801.109 of this chapter (restricted to use by or upon the order of qualified practitioners as determined by the States); and
(3) Labeling for use only in health care facilities and only by persons with specific training and experience in the use of the device.
0
2012
Page 1 of 3
Premarket Notification 510(k) Summary As required by section 807.92
Lullaby™ Warmer
GENERAL COMPANY INFORMATION as required by 807.92(a)(1)
[10th May 2012] Date: Wipro GE Healthcare Private Ltd. Submitter: 4, kadugodi industrial area bangalore, INDIA 560067
Primary Contact Person:
Ms Agata Anthony GE Healthcare, Phone - +1410 456 0329 Fax - +1-410-888-0544
Secondary Contact Person:
Sanjukta DebRoy GE Healthcare, Phone : +91 9632211022 Fax :+9180 28411645
LullabyTM Warmer Device: Trade Name:
Infant Radiant Warmer Common/Usual Name: Warmer, Infant Radiant, Class : II Classification Names: FMT , General Hospital and Personal use Theraputic Devices Product Code: Regulation No: 21 CFR 880.5130
Predicate Device(s): Ohmeda Ohio8 Infant Warmer System (K963058)
The Lullaby™ Warmer is a radiant warmer which provides a micro-Device Description: environment for a premature, new born baby which otherwise might have very little chance of survival as it will not be able to maintain, by itself, its core body temperature. The Lullaby™ Warmer provides a means for the care giver to monitor the baby continuously by giving timely feedback via the different alarm systems and servo controlled thermal feedback mechanism while maintaining a pre-set temperature and thus ensures that the neonate slowly develops the internal organs to enable it to maintain its body temperature.
1
| Indication for Use: | Infant radiant warmers provide infrared heat in a controlled manner to
infants who are unable to maintain thermoregulation based on their own
physiology. Infant radiant warmers may be used to facilitate the
newborn's transition to the external environment or to provide a
controlled open microenvironment. |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Technology: | Lullaby™ Warmer uses the same fundamental technology as its predicate
Ohmeda Ohio® Infant Warmer System providing radiant heat in a controlled
manner to infants who are unable to maintain thermoregulation based on their
own physiology. |
| | The control system uses a microprocessor and provides both manual and servo
modes of operation. The patient temperature, control temperature, Apgar timer,
Audio and visual alarm system are included on the control panel. |
| | The intended use for both predicate and the proposed device is the same only
minor word phrasing differences are there in order to add more clarity. |
| | The Lullaby™ Warmer uses recliner mechanism for bed tilting which offers a
wider tilting angle as compared to the predicate device.
For more on the predicate device comparison refer to section 12 of this 510k
submission. |
·
.
. '
:
.
2
Page 3 of 3
| Determination of Substantial
| Equivalence: | Summary of Non-Clinical Tests: |
|---|---|
| Verification and Testing activities establish the performance, functionality, | |
| usability, safety, and reliability characteristics of Lullaby™ Warmer. | |
| The Lullaby™ Warmer comply with voluntary standards as detailed in | |
| Section 09, 15, 16, 17 and 18 of this premarket submission. | |
| The following quality assurance measures were applied to the development of | |
| the system: | |
| Risk Analysis Requirements Reviews Design Reviews | |
| Summary of Simulated Use Setting: | |
| The Design verification of Lullaby™ Warmer has been divided into several | |
| protocols that include electrical, mechanical, safety Testing, reliability, and | |
| system design verification protocols. | |
| The performance testing included testing on unit level, system level, as well as | |
| usability and safety parameters. | |
| The results of the Design verification testing protocols have been documented | |
| in Section 18 of this 510(k) application. | |
| The results demonstrate that the Lullaby™ Warmer meets all design | |
| requirements and performance claims. | |
| The subject of this premarket submission, Lullaby™ Warmer , did not | |
| require clinical studies to support substantial equivalence. | |
| Conclusion: |
3 .
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle-like symbol with three curved lines representing wings or feathers. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the symbol.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Wipro GE Healthcare Private Ltd. C/O Ms. Agata Anthony Regulatory Affairs Director GE Healthcare 8880 Gorman Road Laurel, Maryland 20723
Re: K121625
Trade/Device Name: Lullaby Warmer Regulation Number: 21 CFR 880.5130 Regulation Name: Infant Radiant Warmer Regulatory Class: II Product Code: FMT Dated: August 14, 2012 Received: August 20, 2012
Dear Ms. Anthony:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
SEP 14 2012
4
Page 2- Ms. Anthony
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Fr
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
K121625 510(k) Number (if known):
Device Name: Lullaby™ Warmer
Indications for Use:
Infant radiant Warmers provide infrared heat in a controlled manner to infants who are unable to maintain thermoregulation based on their own physiology. Infant radiant Warmers may be used to facilitate the newborn's transition to the external environment or to rrovide a controlled open microenvironment.
Prescription Use_
AND/OR
Over-The-Counter Use_
(Part 21 CFR 801 Subpart C)
(Part 21 CFR 801 Subpart D)
.
.
.
.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
fw Richard Chapman
(Division Sign-Off) (Division Sign-Off)
Division of Anesthesiology, General Hospital
Division of Anesthesiology, General Devices Infection Control, Dental D
510(k) Number: K121625